Peregrine Capital Management LLC Sells 9,412 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Peregrine Capital Management LLC cut its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 8.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 103,382 shares of the company’s stock after selling 9,412 shares during the period. Peregrine Capital Management LLC owned approximately 0.12% of HealthEquity worth $9,920,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. UMB Bank n.a. grew its stake in HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares during the period. Quarry LP grew its position in shares of HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after buying an additional 1,089 shares during the period. 1620 Investment Advisors Inc. bought a new stake in shares of HealthEquity in the 3rd quarter valued at $112,000. GAMMA Investing LLC increased its stake in shares of HealthEquity by 32.9% in the 4th quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock valued at $120,000 after acquiring an additional 309 shares in the last quarter. Finally, Covestor Ltd lifted its position in shares of HealthEquity by 27.4% during the 3rd quarter. Covestor Ltd now owns 1,524 shares of the company’s stock valued at $125,000 after acquiring an additional 328 shares during the period. 99.55% of the stock is owned by institutional investors.

Insider Activity at HealthEquity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now owns 19,061 shares in the company, valued at $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the transaction, the director now directly owns 66,469 shares of the company’s stock, valued at $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 39,000 shares of company stock worth $3,895,788. Insiders own 2.20% of the company’s stock.

Wall Street Analysts Forecast Growth

HQY has been the subject of a number of research reports. Royal Bank of Canada raised their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Bank of America raised their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. JMP Securities upped their price target on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Mizuho began coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. Finally, The Goldman Sachs Group started coverage on HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

HealthEquity Stock Performance

NASDAQ HQY opened at $112.69 on Tuesday. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The firm has a market cap of $9.77 billion, a price-to-earnings ratio of 103.39, a PEG ratio of 1.61 and a beta of 0.55. The company has a fifty day moving average price of $102.38 and a 200-day moving average price of $91.18. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the company posted $0.40 earnings per share. As a group, equities research analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.